Cell Biopeutics Resources Sdn Bhd
2 clinical trials · Sponsor
◉ Watch Cell Biopeutics Resources Sdn Bhd
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease (NCT05854641) | Cell Biopeutics Resources Sdn Bhd | 2024-01-01 |
| Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease (NCT05854615) | Cell Biopeutics Resources Sdn Bhd | 2024-01-01 |
Track Cell Biopeutics Resources Sdn Bhd automatically
Every clearance here is in the API, with alerts when new ones post.